Literature DB >> 11001573

Combination of transurethral and interstitial ultrasound applicators for high-temperature prostate thermal therapy.

C J Diederich1, W H Nau, E C Burdette, I S Bustany, D L Deardorff, P R Stauffer.   

Abstract

The purpose of this study was to determine the feasibility of using a transurethral ultrasound applicator in combination with implantable ultrasound applicators for inducing thermal coagulation and necrosis of localized cancer lesions or benign disease within the prostate gland. The potential to treat target zones in the anterior and lateral portions of the prostate with the angularly directive transurethral applicator, while simultaneously treating regions of extracapsular extension and zones in the posterior prostate with the directive implantable applicators in combination with a rectal cooling bolus, is evaluated. Biothermal computer simulations, acoustic characterizations, and in vivo thermal dosimetry experiments with canine prostates were used to evaluate the performance of each applicator type and combinations thereof. Simulations have demonstrated that transurethral applicators with 180-270 degrees acoustic active zones can direct therapeutic heating patterns to the anterior and lateral prostate, implantable needles can isolate heating to the posterior gland while avoiding rectal tissue, and that the combination of applicators can be used to produce conformal heating to the whole gland. Single implantable applicators (1.8 mm OD x 10 mm long, approximately 180 degrees active sector, approximately 7 MHz, direct-coupled type) produced directional thermal lesions within in vivo prostate, with temperatures >50 degrees C extending more than 10 mm radially after 10-15 min. Combination of interstitial applicators (1-2) and a transurethral applicator (3-2.5 mm OD x 6 mm long, approximately 180 degrees active sector, 6.8 MHz, 6 mm OD delivery catheter) produced conforming temperature distributions (48-85 degrees C) and zones of acute thermal damage within 15 min. The preliminary results of this investigation demonstrate that implantable directional ultrasound applicators, in combination with a transurethral ultrasound applicator, have the potential to provide thermal coagulation and necrosis of small or large regions within the prostate gland, while sparing thermally sensitive rectal tissue.

Entities:  

Mesh:

Year:  2000        PMID: 11001573     DOI: 10.1080/026567300416695

Source DB:  PubMed          Journal:  Int J Hyperthermia        ISSN: 0265-6736            Impact factor:   3.914


  7 in total

1.  Multiple applicator hepatic ablation with interstitial ultrasound devices: theoretical and experimental investigation.

Authors:  Punit Prakash; Vasant A Salgaonkar; E Clif Burdette; Chris J Diederich
Journal:  Med Phys       Date:  2012-12       Impact factor: 4.071

Review 2.  Catheter-based ultrasound technology for image-guided thermal therapy: current technology and applications.

Authors:  Vasant A Salgaonkar; Chris J Diederich
Journal:  Int J Hyperthermia       Date:  2015-03-23       Impact factor: 3.914

Review 3.  Focal ablation of prostate cancer: four roles for magnetic resonance imaging guidance.

Authors:  Graham Sommer; Donna Bouley; Harcharan Gill; Bruce Daniel; Kim Butts Pauly; Chris Diederich
Journal:  Can J Urol       Date:  2013-04       Impact factor: 1.344

Review 4.  Modelling of endoluminal and interstitial ultrasound hyperthermia and thermal ablation: applications for device design, feedback control and treatment planning.

Authors:  Punit Prakash; Vasant A Salgaonkar; Chris J Diederich
Journal:  Int J Hyperthermia       Date:  2013-06       Impact factor: 3.914

5.  Applicators for magnetic resonance-guided ultrasonic ablation of benign prostatic hyperplasia.

Authors:  Graham Sommer; Kim Butts Pauly; Andrew Holbrook; Juan Plata; Bruce Daniel; Donna Bouley; Harcharan Gill; Punit Prakash; Vasant Salgaonkar; Peter Jones; Chris Diederich
Journal:  Invest Radiol       Date:  2013-06       Impact factor: 6.016

6.  Transoesophageal ultrasound applicator for sector-based thermal ablation: first in vivo experiments.

Authors:  David Melodelima; Cyril Lafon; Frederic Prat; Yves Theillère; Alexei Arefiev; Dominique Cathignol
Journal:  Ultrasound Med Biol       Date:  2003-02       Impact factor: 2.998

7.  Catheter-based ultrasound hyperthermia with HDR brachytherapy for treatment of locally advanced cancer of the prostate and cervix.

Authors:  Chris J Diederich; Jeff Wootton; Punit Prakash; Vasant Salgaonkar; Titania Juang; Serena Scott; Xin Chen; Adam Cunha; Jean Pouliot; I C Hsu
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2011-02-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.